2022
DOI: 10.21203/rs.3.rs-1338441/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast Cancer

Abstract: Breast cancer ranks first in morbidity and mortality among women worldwide. The immune microenvironment including immune-related long non-coding RNAs (irlncRNAs) are involved in various processes in tumors. We downloaded the RNA-sequencing data and corresponding clinical characteristics of breast samples from TCGA website and obtained the irlncRNAs and identified differentially expressed irlncRNAs (DEirlncRNAs) compared tumor with normal samples. Cox and Lasso regression analysis were used to establish a risk … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 36 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?